Aphali Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.21 M
- Company Age 91 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -7.50%
- Profit Growth 9.57%
- Ebitda -1065.74%
- Net Worth -7.99%
- Total Assets -10.88%
About Aphali Pharmaceuticals
Aphali Pharmaceuticals Limited (APL) was founded in India on 16 October 1933 and has a glorious history of 91 years and seven months.Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.21 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Kasat, Shyam Kasat, Siddharth Kasat, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U27239MH1933PLC002027
- Company No.
002027
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1933
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
What products or services does Aphali Pharmaceuticals Limited offer?
Aphali Pharmaceuticals Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Aphali Pharmaceuticals Limited
Explore comprehensive data for Aphali Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Aphali Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Kasat  | Managing Director | 24-Apr-1979 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddharth Kasat | Director | 10-Jul-2023 | Current |
| Seema Kasat | Director | 30-Jan-1996 | Current |
| Aniruddha Kasat | Director | 10-Mar-2016 | Current |
Financial Performance of Aphali Pharmaceuticals.
Aphali Pharmaceuticals Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 7.5% decrease. The company also saw a slight improvement in profitability, with a 9.57% increase in profit. The company's net worth dipped by a decrease of 7.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aphali Pharmaceuticals?
In 2017, Aphali Pharmaceuticals had a promoter holding of 48.24% and a public holding of 51.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Farmak Private LimitedSeema Kasat and Shyam Kasat are mutual person
- Tarujyot Investments Limited
Shyam Kasat and Siddharth Kasat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aphali Pharmaceuticals?
Aphali Pharmaceuticals has a workforce of 17 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aphali Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aphali Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aphali Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Aphali Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Aphali Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Siddharth Shyamkumar Kasat was appointed as a Director was appointed as a Director on 10 Jul 2023 & has been associated with this company since 1 year 10 months .
- Director Appointment
Aniruddha Shyamkumar Kasat was appointed as a Director was appointed as a Director on 10 Mar 2016 & has been associated with this company since 9 years 2 months .
- Director Appointment
Seema Shyam Kasat was appointed as a Director was appointed as a Director on 30 Jan 1996 & has been associated with this company since 29 years 3 months .
- Director Appointment
Shyam Hariwilas Kasat was appointed as a Managing Director was appointed as a Managing Director on 24 Apr 1979 & has been associated with this company since 46 years 25 days .
Frequently asked questions
What is the Incorporation or founding date of Aphali Pharmaceuticals Limited?
Aphali Pharmaceuticals Limited was incorporated on 16 Oct 1933.
What is authorized share capital and paid-up capital of Aphali Pharmaceuticals Limited?
The authorized share capital of Aphali Pharmaceuticals Limited is ₹ 2.50 M and paid-up capital is ₹ 2.21 M.
Who are the current board members & directors of Aphali Pharmaceuticals Limited?
Currently 4 directors are associated with Aphali Pharmaceuticals Limited.
- Seema Shyam Kasat
- Shyam Hariwilas Kasat
- Siddharth Shyamkumar Kasat
- Aniruddha Shyamkumar Kasat
What is the registered address of Aphali Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aphali Pharmaceuticals Limited is 406 Auto Commerce House Near Kennedy Bridge Nana Chowk, Grant R Oad India, Mumbai, Maharashtra, 400007.
What is the corporate identification number (CIN) and company number of Aphali Pharmaceuticals Limited?
The corporate identification number (CIN) of Aphali Pharmaceuticals Limited is U27239MH1933PLC002027 and the company number is 002027 as per Ministry of Corporate Affairs (MCA).
What is the official website of Aphali Pharmaceuticals Limited?
The Official website of Aphali Pharmaceuticals Limited is https://www.aphali.com
What has been the recent revenue trend for Aphali Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2017, the revenue trend for Aphali Pharmaceuticals Limited has fallen by -7.50%.
How many employees does Aphali Pharmaceuticals Limited currently have?
As Per 2017 financial reports, 17 employees are currently employed by Aphali Pharmaceuticals Limited.
What change has been observed in the net worth of Aphali Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Aphali Pharmaceuticals Limited has experienced an downturn of -7.99%.
When was the last Balance Sheet of Aphali Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Aphali Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records